# FDA Inspection 1010321 - Community Blood Center - May 04, 2017

Source: https://www.keypedia.com/records/fda_inspections/community-blood-center/2555693d-e14c-409e-b7b8-fa6d8d8bb214
Source feed: FDA_Inspections

> FDA Inspection 1010321 for Community Blood Center on May 04, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1010321
- Company Name: Community Blood Center
- Inspection Date: 2017-05-04
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1165920 - 2022-03-11](https://www.keypedia.com/records/fda_inspections/community-blood-center/b50afd15-118d-4473-b8a4-4c12a47ca34b)
- [FDA Inspection 1165920 - 2022-03-11](https://www.keypedia.com/records/fda_inspections/community-blood-center/e465550f-52c9-422f-8548-ee837b418604)
- [FDA Inspection 1010321 - 2017-05-04](https://www.keypedia.com/records/fda_inspections/community-blood-center/2ad02786-44f9-49a5-9af7-d01cccd3c322)
- [FDA Inspection 888021 - 2014-07-11](https://www.keypedia.com/records/fda_inspections/community-blood-center/ce61795b-038e-4d99-af41-6a3484d2f080)
- [FDA Inspection 781074 - 2012-05-11](https://www.keypedia.com/records/fda_inspections/community-blood-center/aa71c888-825d-4114-b5a5-0d3485814dc6)

Company: https://www.keypedia.com/companies/community-blood-center/34a9bcc5-6564-41c8-95dd-d2c9647d93ed

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d